Executive Summary: Treatment of Osteoporosis and Osteoarthritis in the Oldest Old.

IF 3.4 3区医学 Q2 GERIATRICS & GERONTOLOGY

Drugs & Aging Pub Date : 2025-03-01 Epub Date: 2025-02-24 DOI:10.1007/s40266-025-01184-7

Nicola Veronese, Nicholas C Harvey, René Rizzoli, Nicholas R Fuggle, Jean-Yves Reginster

引用次数: 0

Abstract

This is the executive summary of a work by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) (Nicholas Fuggle et al. in Drugs, 2024).

查看原文本刊更多论文

内容摘要：老年人骨质疏松症和骨关节炎的治疗。

这是欧洲骨质疏松症、骨关节炎和肌肉骨骼疾病临床和经济方面学会（ESCEO）的一项工作的执行摘要（Nicholas Fuggle et al. in Drugs, 2024）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drugs & Aging 医学-老年医学

CiteScore

5.50

自引率

7.10%

发文量

审稿时长

6-12 weeks

期刊介绍： Drugs & Aging delivers essential information on the most important aspects of drug therapy to professionals involved in the care of the elderly. The journal addresses in a timely way the major issues relating to drug therapy in older adults including: the management of specific diseases, particularly those associated with aging, age-related physiological changes impacting drug therapy, drug utilization and prescribing in the elderly, polypharmacy and drug interactions.